The rejection may make the pharma firms remaining lawsuits more difficult.

The Supreme Court has rejected appeals from pharmaceutical companies that object to negotiating Medicare drug prices with the federal government.

Pharmaceutical companies are trying to prevent Medicare from negotiating discounts for drugs. Their legal challenges have been unsuccessful.